Cargando…
High-Risk Drug–Drug Interactions Between Clinical Practice Guidelines for Management of Chronic Conditions
Clinicians and clinical decision-support systems often follow pharmacotherapy recommendations for patients based on clinical practice guidelines (CPGs). In multimorbid patients, these recommendations can potentially have clinically significant drug–drug interactions (DDIs). In this study, we describ...
Autores principales: | Tso, Geoffrey J., Tu, Samson W., Musen, Mark A., Goldstein, Mary K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Informatics Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543385/ https://www.ncbi.nlm.nih.gov/pubmed/28815153 |
Ejemplares similares
-
Automating Identification of Multiple Chronic Conditions in Clinical Practice Guidelines
por: Leung, Tiffany I., et al.
Publicado: (2015) -
Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study
por: Tinetti, Mary E, et al.
Publicado: (2015) -
Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
Publicado: (2014) -
Quality of the Indian clinical practice guidelines for the management of cardiovascular conditions
por: Dhurjati, Rupasvi, et al.
Publicado: (2022) -
A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs
por: Molenaar-Kuijsten, Laura, et al.
Publicado: (2021)